YahooOctober 22, 2026 at 5:57 PM NY5 Days Ago
Aardvark Therapeutics stock surges as FDA lifts clinical hold
Investing.com -- Aardvark Therapeutics Inc (NASDAQ:AARD) shares jumped 21% in after-hours trading Thursday after the FDA lifted the clinical hold on the company's ARD-101 drug candidate for the treatment of hyperphagia in Prader-Willi Syndrome.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
